Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision tag changes from v3.6.2 to v3.6.3, reflecting a small template update. It does not alter the study details or how information is presented to users.SummaryDifference0.1%

- Check18 days agoChange DetectedA new page revision label, v3.6.2, has been added. The previous revision label, v3.6.0, was removed, indicating an update to the page content.SummaryDifference0.1%

- Check32 days agoChange DetectedA recruitment status notice 'No longer looking for participants' was added, indicating the study is not enrolling. New help and navigation items—'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'—were added, and the 'Intervention / Treatment' heading was reformatted to 'Intervention/Treatment' while the old 'Revision: v3.5.5' note was removed in favor of 'Revision: v3.6.0'.SummaryDifference0.4%

- Check39 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the study record display.SummaryDifference0.1%

- Check61 days agoChange DetectedThe revision label at the bottom of the page changes from Revision: v3.5.3 to Revision: v3.5.4, indicating a minor update to the page’s version history rather than updates to study content.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now shows an updated revision label (v3.5.3 instead of v3.5.2), indicating a minor site/package update rather than a change to the underlying study information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.